BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 38672121)

  • 1. Diabetic Cardiomyopathy-From Basics through Diagnosis to Treatment.
    Radzioch E; Dąbek B; Balcerczyk-Lis M; Frąk W; Fularski P; Młynarska E; Rysz J; Franczyk B
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical characteristics of diabetic cardiomyopathy in patients with acute heart failure.
    Matsushita K; Harada K; Kohno T; Nakano H; Kitano D; Matsuda J; Takei M; Yoshino H; Yamamoto T; Nagao K; Takayama M
    Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1325-1333. PubMed ID: 38218713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
    Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
    Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.
    Kaur N; Guan Y; Raja R; Ruiz-Velasco A; Liu W
    Front Physiol; 2021; 12():694864. PubMed ID: 34234695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the treatment of diabetic cardiomyopathy, a systematic review.
    Shou Y; Li X; Fang Q; Xie A; Zhang Y; Fu X; Wang M; Gong W; Zhang X; Yang D
    Pharmacol Res Perspect; 2024 Apr; 12(2):e1177. PubMed ID: 38407563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
    Zhang T; Gao Z; Chen K
    J Cardiol; 2022 Nov; 80(5):423-431. PubMed ID: 35000826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies.
    Ghosh N; Chacko L; Bhattacharya H; Vallamkondu J; Nag S; Dey A; Karmakar T; Reddy PH; Kandimalla R; Dewanjee S
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells and diabetic cardiomyopathy: from pathology to therapy.
    Liu M; Chen H; Jiang J; Zhang Z; Wang C; Zhang N; Dong L; Hu X; Zhu W; Yu H; Wang J
    Heart Fail Rev; 2016 Nov; 21(6):723-736. PubMed ID: 27221074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate Clinical Characteristics and Prognosis of HFpEF versus HFrEF Phenotype of Diabetic Cardiomyopathy.
    Li Z; Shi Y; Xia Y; Wu L; Li H; Zhou R; Gao X; Zhang H; Jin X; Zhang J
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Exercise and Its Protective Effects on Diabetic Cardiomyopathy: What Is the Evidence?
    Zheng J; Cheng J; Zheng S; Zhang L; Guo X; Zhang J; Xiao X
    Front Endocrinol (Lausanne); 2018; 9():729. PubMed ID: 30559720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy.
    Tao L; Huang X; Xu M; Qin Z; Zhang F; Hua F; Jiang X; Wang Y
    Mol Cell Endocrinol; 2020 Dec; 518():110944. PubMed ID: 32717421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening, diagnosis and management of diabetes mellitus and diabetic complications].
    Lehmann R; Spinas GA
    Ther Umsch; 2000 Jan; 57(1):12-21. PubMed ID: 10667077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
    Alonso N; Moliner P; Mauricio D
    Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.